Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17706
Country/Region: Uganda
Year: 2017
Main Partner: Makerere University
Main Partner Program: Infectious Disease Institute
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $10,932,012 Additional Pipeline Funding: $4,391,049

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,202,436
Care: Orphans and Vulnerable Children (HKID) $244,575
Care: TB/HIV (HVTB) $446,998
Care: Pediatric Care and Support (PDCS) $210,118
Laboratory Infrastructure (HLAB) $61,987
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $754,316
Testing: HIV Testing and Counseling (HVCT) $2,024,713
Sexual Prevention: Other Sexual Prevention (HVOP) $50,615
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $594,275
Treatment: Adult Treatment (HTXS) $4,202,565
Treatment: Pediatric Treatment (PDTX) $139,414
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 263
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 53
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 511
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 102
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 1,785
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 355
GEND_GBV Number of people receiving post-GBV care 2018 2,559
GEND_GBV Number of people receiving post-GBV care 2018 510
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 192,573
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 785,706
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2018 419
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2018 3,732
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2018 634
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2018 652
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 55
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 1
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 208
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 41
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 1,616
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 1,004
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 143
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 107
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 201
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 595
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 395
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 999
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 377
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 999
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 196
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 196
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 43,254
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 10,011
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 50,433
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 11,675
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 43,254
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 10,011
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 7,217
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 1,669
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 793
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 162
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 9,253
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 845
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 1,401
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 164
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 1,691
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 129
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 242
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 70
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 26
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 872
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 218
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 212
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 59
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 5,649
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 1,711
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 3,707
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 1,072
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 570
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 171
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 460
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 134
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 313
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 1,496
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 1,542
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 17,368
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 300
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 2,483
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 237
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 3,330
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 1,073
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 7,510
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 162
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 838
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 3,344
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 26,381
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 720
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 6,151
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 22,063
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 121,395
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 12,612
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 79,139
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 2,182
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 12,129
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 1,581
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 10,140
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 709
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 193
HTS_TST Service Delivery Point (Facility) Other PITC: <1, Negative 2018 1,469
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 1,545
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 17,387
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 299
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 2,545
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 236
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 3,285
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 862
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 5,476
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 132
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 547
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 2,703
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 19,865
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 545
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 4,915
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 18,661
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 102,235
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 10,460
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 75,823
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 1,838
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 10,254
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 1,305
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 9,817
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 1,300
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 13,138
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 46
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 26
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 484
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 125
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 22
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 61
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 117
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 20
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 47
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 10
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 358
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 85
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 188
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 45
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 11
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 6
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 10,194
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 13,787
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 11,885
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 16,082
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 10,194
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 13,787
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 1,700
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 2,297
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 306
HTS_TST Sum of Test Result disaggregates 2018 9,076
HTS_TST Sum of Test Result disaggregates 2018 25,558
HTS_TST_POS By Test Result: Positive 2018 9,076
HTS_TST_POS By Test Result: Positive 2018 25,558
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2018 53
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 106
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 961
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 565
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2018 70
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 54
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 19
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 58
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 37
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 122
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive 2018 52
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 111
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2018 17
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 780
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 210
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 894
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 242
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 780
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 210
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 123
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 108
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 140
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 39
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 492
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 121
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 117
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 3,183
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 965
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 2,080
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 603
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 317
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 95
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 261
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 76
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 178
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 35
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 194
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 111
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 696
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 25
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 155
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 728
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 3,498
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 439
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 2,220
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 71
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 356
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 55
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 285
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 184
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 33
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 35
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 159
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 111
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 585
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 150
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 916
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 3,453
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 543
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 2,326
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 91
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 347
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 67
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 298
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 146
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 179
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 37
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 64
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 75
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 104
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 211
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 285
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 242
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 328
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 29
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 4,202
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 4,202
OVC_SERV Age/Sex: <1 2018 171
OVC_SERV Age/Sex: 1-9 2018 1,449
OVC_SERV Age/Sex: 10-14 Female 2018 574
OVC_SERV Age/Sex: 10-14 Male 2018 394
OVC_SERV Age/Sex: 15-17 Female 2018 306
OVC_SERV Age/Sex: 15-17 Male 2018 374
OVC_SERV By: Age/sex: 18-24 Female 2018 460
OVC_SERV By: Age/sex: 25+ Female 2018 129
OVC_SERV By: Age/sex: Male 18-24 2018 399
OVC_SERV By: Age/sex: Male 25+ 2018 92
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 4,348
OVC_SERV Program Completion: Active 2018 3,285
OVC_SERV Program Completion: Exited without graduation 2018 210
OVC_SERV Program Completion: Graduation 2018 631
OVC_SERV Program Completion: Transferred 2018 222
OVC_SERV Sum of Age/Sex disaggregates 2018 1,648
PMTCT_ART Already on ART at beginning of current pregnancy 2018 3,166
PMTCT_ART Already on ART at beginning of current pregnancy 2018 593
PMTCT_ART New on ART 2018 2,621
PMTCT_ART New on ART 2018 493
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 5,787
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,086
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 158,762
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 28,047
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 870
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 4,648
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,342
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 251
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 3,079
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 577
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 65
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 13
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 29
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 162
PMTCT_STAT By Age (Numerator): : 15-19 2018 30,153
PMTCT_STAT By Age (Numerator): 10-14 2018 1,585
PMTCT_STAT By Age (Numerator): 10-14 2018 280
PMTCT_STAT By Age (Numerator): 15-19 2018 5,329
PMTCT_STAT By Age (Numerator): 20-24 2018 30,153
PMTCT_STAT By Age (Numerator): 20-24 2018 5,329
PMTCT_STAT By Age (Numerator): 25-49 2018 96,871
PMTCT_STAT By Age (Numerator): 25-49 2018 17,109
PMTCT_STAT By known positives: 10-14 2018 11
PMTCT_STAT By known positives: 15-19 2018 635
PMTCT_STAT By known positives: 20-24 2018 1,118
PMTCT_STAT By known positives: 25-49 2018 1,529
PMTCT_STAT By new negatives: 10-14 2018 1,565
PMTCT_STAT By new negatives: 15-19 2018 28,982
PMTCT_STAT By new negatives: 20-24 2018 28,084
PMTCT_STAT By new negatives: 25-49 2018 94,037
PMTCT_STAT By new positives: 10-14 2018 8
PMTCT_STAT By new positives: 15-19 2018 535
PMTCT_STAT By new positives: 20-24 2018 950
PMTCT_STAT By new positives: 25-49 2018 1,308
PMTCT_STAT By Number of known positives: 10-14 2018 4
PMTCT_STAT By Number of known positives: 15-19 2018 115
PMTCT_STAT By Number of known positives: 20-24 2018 208
PMTCT_STAT By Number of known positives: 25-49 2018 282
PMTCT_STAT By Number of new negative: 10-14 2018 272
PMTCT_STAT By Number of new negative: 15-19 2018 5,114
PMTCT_STAT By Number of new negative: 20-24 2018 4,938
PMTCT_STAT By Number of new negative: 25-49 2018 16,582
PMTCT_STAT By Number of new positives: 10-14 2018 4
PMTCT_STAT By Number of new positives: 15-19 2018 100
PMTCT_STAT By Number of new positives: 20-24 2018 181
PMTCT_STAT By Number of new positives: 25-49 2018 247
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 158,762
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 28,047
PMTCT_STAT_den By Age (Denominator): <15-19 2018 5,329
PMTCT_STAT_den By Age (Denominator): 10-14 2018 1,585
PMTCT_STAT_den By Age (Denominator): 10-14 2018 280
PMTCT_STAT_den By Age (Denominator): 15-19 2018 30,153
PMTCT_STAT_den By Age (Denominator): 20-24 2018 30,153
PMTCT_STAT_den By Age (Denominator): 20-24 2018 5,329
PMTCT_STAT_den By Age (Denominator): 25-49 2018 96,871
PMTCT_STAT_den By Age (Denominator): 25-49 2018 17,109
PP_PREV Age/sex: 10-14 Female 2018 225
PP_PREV Age/sex: 10-14 Male 2018 176
PP_PREV Age/sex: 15-19 Female 2018 113
PP_PREV Age/sex: 15-19 Male 2018 93
PP_PREV Age/sex: 20-24 Female 2018 81
PP_PREV Age/sex: 20-24 Male 2018 84
PP_PREV Age/sex: 25-49 Female 2018 255
PP_PREV Age/sex: 25-49 Male 2018 291
PP_PREV Age/sex: 50+ Female 2018 19
PP_PREV Age/sex: 50+ Male 2018 20
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 1,357
PP_PREV Sum of Age/Sex disaggregates 2018 1,357
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 16
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 15
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 316
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 162
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 26
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 17
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 600
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 297
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,008
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 516
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 958
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 491
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 17
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 15
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 325
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 170
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 28
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 18
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 638
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 313
TB_PREV By Age/Sex (Numerator): <15, Female 2018 169
TB_PREV By Age/Sex (Numerator): <15, Female 2018 76
TB_PREV By Age/Sex (Numerator): <15, Male 2018 148
TB_PREV By Age/Sex (Numerator): <15, Male 2018 67
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 5,154
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 3,581
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 3,188
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,990
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 8,659
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 5,714
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 8,659
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 5,714
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 17,305
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 11,430
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 430
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 155
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 336
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 136
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 10,310
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 7,163
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 6,229
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 3,976
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 17,305
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 11,430
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 93
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 41
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,160
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 476
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 126
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 58
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,125
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 867
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 3,504
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,442
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 3,504
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,442
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 93
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 41
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,160
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 476
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 126
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 58
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,125
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 867
TX_CURR Age/Sex: <1 2018 188
TX_CURR Age/Sex: <1 2018 100
TX_CURR Age/Sex: <1-9 2018 1,561
TX_CURR Age/Sex: 1-9 2018 3,095
TX_CURR Age/Sex: 10-14 Female 2018 1,001
TX_CURR Age/Sex: 10-14 Female 2018 503
TX_CURR Age/Sex: 10-14 Male 2018 716
TX_CURR Age/Sex: 10-14 Male 2018 352
TX_CURR Age/Sex: 15-19 Female 2018 1,665
TX_CURR Age/Sex: 15-19 Female 2018 1,122
TX_CURR Age/Sex: 15-19 Male 2018 250
TX_CURR Age/Sex: 15-19 Male 2018 201
TX_CURR Age/Sex: 20-24 Female 2018 5,305
TX_CURR Age/Sex: 20-24 Female 2018 3,557
TX_CURR Age/Sex: 20-24 Male 2018 1,102
TX_CURR Age/Sex: 20-24 Male 2018 852
TX_CURR Age/Sex: 25-49 Female 2018 29,414
TX_CURR Age/Sex: 25-49 Female 2018 22,041
TX_CURR Age/Sex: 25-49 Male 2018 17,242
TX_CURR Age/Sex: 25-49 Male 2018 12,445
TX_CURR Age/Sex: 50+ Female 2018 2,912
TX_CURR Age/Sex: 50+ Female 2018 2,179
TX_CURR Age/Sex: 50+ Male 2018 2,126
TX_CURR Age/Sex: 50+ Male 2018 1,538
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 65,016
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 46,451
TX_CURR Sum of age/sex disaggregates 2018 1,323
TX_CURR Sum of Age/Sex disaggregations 2018 1,915
TX_NEW Breastfeeding status 2018 45
TX_NEW Breastfeeding status 2018 39
TX_NEW By Age/Sex: <1 2018 157
TX_NEW By Age/Sex: <1 2018 103
TX_NEW By Age/Sex: 1-9 2018 489
TX_NEW By Age/Sex: 1-9 2018 163
TX_NEW By Age/Sex: 10-14 Female 2018 90
TX_NEW By Age/Sex: 10-14 Female 2018 33
TX_NEW By Age/Sex: 10-14 Male 2018 84
TX_NEW By Age/Sex: 10-14 Male 2018 25
TX_NEW By Age/Sex: 15-19 Female 2018 461
TX_NEW By Age/Sex: 15-19 Female 2018 271
TX_NEW By Age/Sex: 15-19 Male 2018 72
TX_NEW By Age/Sex: 15-19 Male 2018 45
TX_NEW By Age/Sex: 20-24 Female 2018 1,513
TX_NEW By Age/Sex: 20-24 Female 2018 848
TX_NEW By Age/Sex: 20-24 Male 2018 374
TX_NEW By Age/Sex: 20-24 Male 2018 201
TX_NEW By Age/Sex: 25-49 Female 2018 8,618
TX_NEW By Age/Sex: 25-49 Female 2018 6,221
TX_NEW By Age/Sex: 25-49 Male 2018 5,784
TX_NEW By Age/Sex: 25-49 Male 2018 3,712
TX_NEW By Age/Sex: 50+ Female 2018 853
TX_NEW By Age/Sex: 50+ Female 2018 617
TX_NEW By Age/Sex: 50+ Male 2018 723
TX_NEW By Age/Sex: 50+ Male 2018 461
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 19,218
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 12,700
TX_NEW Pregnancy status 2018 4,826
TX_NEW Pregnancy status 2018 3,177
TX_NEW Sum of Age/Sex disaggregates 2018 18,572
TX_NEW Sum of Age/Sex disaggregates 2018 12,434
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 58,524
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 41,807
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 52,667
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 37,627
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,226
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,120
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,823
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 918
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 31,845
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 23,404
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 16,773
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 12,185
TX_PVLS Numerator: Indication: Routine 2018 52,667
TX_PVLS Numerator: Indication: Routine 2018 37,627
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 278
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 187
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 5,283
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 3,762
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,501
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,245
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,043
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,020
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 35,325
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 26,001
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 18,655
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 13,541
TX_PVLS_den Denominator: Indication: Routine 2018 58,524
TX_PVLS_den Denominator: Indication: Routine 2018 41,807
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 293
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 208
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 5,856
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 4,179
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 357
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 131
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 316
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 115
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 5,600
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,017
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3,284
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,191
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 9,557
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 3,454
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 10,570
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 3,813
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 357
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 131
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 316
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 115
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,213
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,241
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,684
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,326
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 65,016
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 46,451
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 1,301
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 930
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 36
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 29
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 30
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 23
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 790
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 578
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 445
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 300
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 2,753
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,383
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 2,247
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 1,133
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 39,303
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 20,713
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 28,892
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 15,043
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 3,652
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 2,602
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 508
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 372
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,041
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 743
TX_TB_den Denominator: By Screen Result: Negative 2018 59,815
TX_TB_den Denominator: By Screen Result: Negative 2018 42,734
TX_TB_den Denominator: By Screen Result: Positive 2018 5,201
TX_TB_den Denominator: By Screen Result: Positive 2018 3,717
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 5,201
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 3,717
VMMC_CIRC By Age: 10-14 2018 9,019
VMMC_CIRC By Age: 15-19 2018 16,230
VMMC_CIRC By Age: 20-24 2018 21,644
VMMC_CIRC By Age: 25-29 2018 34,257
VMMC_CIRC By Age: 30-49 2018 5,411
VMMC_CIRC By Age: 50+ 2018 3,611
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 90,172
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 90,172
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 50,504
Cross Cutting Budget Categories and Known Amounts Total: $6,304,714
Gender: Gender Based Violence (GBV) $200,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Gender: Gender Equality $200,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Motor Vehicles: Purchased $210,000
Food and Nutrition: Policy, Tools, and Service Delivery $50,233
Water $50,233
Renovation $125,000
Food and Nutrition: Commodities $25,116
Human Resources for Health $5,444,132